Biotech

All Articles

ArsenalBio raises $325M, rotates far from former lead property

.Toolbox Biosciences is moving on up. The cell therapy company has actually added on $325 thousand i...

Lilly- supported weight management biotech files IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has actually su...

Aelis' marijuana make use of medication flunks phase 2b, driving Indivior to rethink $100M choice

.Aelis Farma's chances of protecting a fast, beneficial choice on a $one hundred thousand option pay...

ProKidney stops phase 3 trial certainly not needed for tissue therapy permission

.ProKidney has quit among a set of period 3 tests for its cell treatment for renal health condition ...

Vaxcyte climbs on 'impressive' 31-valent PCV win against Pfizer

.Vaxcyte introduced what experts named "stunning" phase 1/2 information for its own 31-valent pneumo...

Recursion's brain disease test presents insufficient documentation of effectiveness

.Recursion has discovered with an early exam of its own tech-enabled strategy to medication explorat...

Acepodia, Pfizer click with each other for chemistry-based cell treatment

.Contact it an instance of really good chemistry: Acepodia, a biotech based on Nobel Champion scienc...

Praxis epilepsy medicine lessens seizures in phase 2 trial

.Praxis Accuracy Medicines has actually racked up yet another midphase win in epilepsy this year, wi...

Three officers surrender as Dyne articles mixed data for DMD prospect

.After escaping a professional grip several years back, Dyne Rehab has actually revealed new period ...

Arrowhead fires off period 3 information in rare metabolic illness in advance of market clash with Ionis

.Arrowhead Pharmaceuticals has revealed its hand ahead of a prospective showdown along with Ionis, p...